148 related articles for article (PubMed ID: 34298711)
1. Clinical Outcomes of Pencil Beam Scanning Proton Therapy in Locally Advanced Non-Small Cell Lung Cancer: Propensity Score Analysis.
Kim N; Noh JM; Lee W; Park B; Pyo H
Cancers (Basel); 2021 Jul; 13(14):. PubMed ID: 34298711
[TBL] [Abstract][Full Text] [Related]
2. Proton beam therapy reduces the risk of severe radiation-induced lymphopenia during chemoradiotherapy for locally advanced non-small cell lung cancer: A comparative analysis of proton versus photon therapy.
Kim N; Myoung Noh J; Lee W; Park B; Park H; Young Park J; Pyo H
Radiother Oncol; 2021 Mar; 156():166-173. PubMed ID: 33359267
[TBL] [Abstract][Full Text] [Related]
3. Reduced radiation exposure to circulating blood cells in proton therapy compared with X-ray therapy in locally advanced lung cancer: Computational simulation based on circulating blood cells.
Kim N; Shin J; Ahn SH; Pyo H; Noh JM; Yang K; Lee W; Park B
Front Oncol; 2023; 13():1119173. PubMed ID: 36923437
[TBL] [Abstract][Full Text] [Related]
4. Impact of Intensity-Modulated Radiation Therapy Technique for Locally Advanced Non-Small-Cell Lung Cancer: A Secondary Analysis of the NRG Oncology RTOG 0617 Randomized Clinical Trial.
Chun SG; Hu C; Choy H; Komaki RU; Timmerman RD; Schild SE; Bogart JA; Dobelbower MC; Bosch W; Galvin JM; Kavadi VS; Narayan S; Iyengar P; Robinson CG; Wynn RB; Raben A; Augspurger ME; MacRae RM; Paulus R; Bradley JD
J Clin Oncol; 2017 Jan; 35(1):56-62. PubMed ID: 28034064
[TBL] [Abstract][Full Text] [Related]
5. Clinical Outcome After Pencil Beam Scanning Proton Therapy of Patients With Non-Metastatic Malignant and Benign Peripheral Nerve Sheath Tumors.
Bachmann N; Leiser D; Pica A; Bachtiary B; Weber DC
Front Oncol; 2022; 12():881665. PubMed ID: 35832560
[TBL] [Abstract][Full Text] [Related]
6. Scanning Beam Proton Therapy versus Photon IMRT for Stage III Lung Cancer: Comparison of Dosimetry, Toxicity, and Outcomes.
Zou Z; Bowen SR; Thomas HMT; Sasidharan BK; Rengan R; Zeng J
Adv Radiat Oncol; 2020; 5(3):434-443. PubMed ID: 32529138
[TBL] [Abstract][Full Text] [Related]
7. First Clinical Report of Proton Beam Therapy for Postoperative Radiotherapy for Non-Small-Cell Lung Cancer.
Remick JS; Schonewolf C; Gabriel P; Doucette A; Levin WP; Kucharczuk JC; Singhal S; Pechet TTV; Rengan R; Simone CB; Berman AT
Clin Lung Cancer; 2017 Jul; 18(4):364-371. PubMed ID: 28162946
[TBL] [Abstract][Full Text] [Related]
8. Early Outcomes of Patients With Locally Advanced Non-small Cell Lung Cancer Treated With Intensity-Modulated Proton Therapy Versus Intensity-Modulated Radiation Therapy: The Mayo Clinic Experience.
Yu NY; DeWees TA; Liu C; Daniels TB; Ashman JB; Beamer SE; Jaroszewski DE; Ross HJ; Paripati HR; Rwigema JM; Ding JX; Shan J; Liu W; Schild SE; Sio TT
Adv Radiat Oncol; 2020; 5(3):450-458. PubMed ID: 32529140
[TBL] [Abstract][Full Text] [Related]
9. Intensity-Modulated Radiation Therapy May Improve Local-Regional Tumor Control for Locally Advanced Non-Small Cell Lung Cancer Compared With Three-Dimensional Conformal Radiation Therapy.
Wang J; Zhou Z; Liang J; Feng Q; Xiao Z; Hui Z; Wang X; Lv J; Chen D; Zhang H; Ji Z; Cao J; Liu L; Jiang W; Men Y; Xu C; Dai J; Yin W; Wang L
Oncologist; 2016 Dec; 21(12):1530-1537. PubMed ID: 27628491
[TBL] [Abstract][Full Text] [Related]
10. Empirical Relative Biological Effectiveness (RBE) for Mandible Osteoradionecrosis (ORN) in Head and Neck Cancer Patients Treated With Pencil-Beam-Scanning Proton Therapy (PBSPT): A Retrospective, Case-Matched Cohort Study.
Yang Y; Muller OM; Shiraishi S; Harper M; Amundson AC; Wong WW; McGee LA; Rwigema JM; Schild SE; Bues M; Fatyga M; Anderson JD; Patel SH; Foote RL; Liu W
Front Oncol; 2022; 12():843175. PubMed ID: 35311159
[TBL] [Abstract][Full Text] [Related]
11. Comparison of Toxicity Between Intensity-Modulated Radiotherapy and 3-Dimensional Conformal Radiotherapy for Locally Advanced Non-small-cell Lung Cancer.
Ling DC; Hess CB; Chen AM; Daly ME
Clin Lung Cancer; 2016 Jan; 17(1):18-23. PubMed ID: 26303127
[TBL] [Abstract][Full Text] [Related]
12. Dosimetric and NTCP advantages of robust proton therapy over robust VMAT for Stage III NSCLC in the immunotherapy era.
Dionisi F; Landoni V; Widesott L; Nardangeli A; Fracchiolla F; Siniscalchi B; Soriani A; Turkaj A; Righetto R; Amelio D; Farace P; Goanta L; Trianni A; Lorentini S; Cianchetti M; Sanguineti G
Phys Med; 2024 Jun; 123():103410. PubMed ID: 38878630
[TBL] [Abstract][Full Text] [Related]
13. Simultaneous integrated boost intensity-modulated radiotherapy for locally advanced non-small cell lung cancer in Chinese population: A retrospective study.
Xu Y; Zheng X; Bai X; Li P; Ma H; Wang J; Hu X; Chen M
Oncotarget; 2017 Jul; 8(30):49084-49092. PubMed ID: 28467775
[TBL] [Abstract][Full Text] [Related]
14. Long-Term Clinical Safety of High-Dose Proton Radiation Therapy Delivered With Pencil Beam Scanning Technique for Extracranial Chordomas and Chondrosarcomas in Adult Patients: Clinical Evidence of Spinal Cord Tolerance.
Stieb S; Snider JW; Placidi L; Kliebsch U; Lomax AJ; Schneider RA; Weber DC
Int J Radiat Oncol Biol Phys; 2018 Jan; 100(1):218-225. PubMed ID: 29029887
[TBL] [Abstract][Full Text] [Related]
15. Treatment of oral cavity squamous cell carcinoma with adjuvant or definitive intensity-modulated radiation therapy.
Sher DJ; Thotakura V; Balboni TA; Norris CM; Haddad RI; Posner MR; Lorch J; Goguen LA; Annino DJ; Tishler RB
Int J Radiat Oncol Biol Phys; 2011 Nov; 81(4):e215-22. PubMed ID: 21531515
[TBL] [Abstract][Full Text] [Related]
16. Proton Beam Radiotherapy and Concurrent Chemotherapy for Unresectable Stage III Non-Small Cell Lung Cancer: Final Results of a Phase 2 Study.
Chang JY; Verma V; Li M; Zhang W; Komaki R; Lu C; Allen PK; Liao Z; Welsh J; Lin SH; Gomez D; Jeter M; O'Reilly M; Zhu RX; Zhang X; Li H; Mohan R; Heymach JV; Vaporciyan AA; Hahn S; Cox JD
JAMA Oncol; 2017 Aug; 3(8):e172032. PubMed ID: 28727865
[TBL] [Abstract][Full Text] [Related]
17. Dosimetric comparison between proton beam therapy and photon radiation therapy for locally advanced esophageal squamous cell carcinoma.
Hirano Y; Onozawa M; Hojo H; Motegi A; Zenda S; Hotta K; Moriya S; Tachibana H; Nakamura N; Kojima T; Akimoto T
Radiat Oncol; 2018 Feb; 13(1):23. PubMed ID: 29426342
[TBL] [Abstract][Full Text] [Related]
18. An esophagus-sparing technique to limit radiation esophagitis in locally advanced non-small cell lung cancer treated by simultaneous integrated boost intensity-modulated radiotherapy and concurrent chemotherapy.
Ma L; Qiu B; Li Q; Chen L; Wang B; Hu Y; Liu M; Zhang L; Huang Y; Deng X; Xia Y; Lin M; Liu H
Radiat Oncol; 2018 Jul; 13(1):130. PubMed ID: 30016978
[TBL] [Abstract][Full Text] [Related]
19. Simultaneous Integrated Boost for Radiation Dose Escalation to the Gross Tumor Volume With Intensity Modulated (Photon) Radiation Therapy or Intensity Modulated Proton Therapy and Concurrent Chemotherapy for Stage II to III Non-Small Cell Lung Cancer: A Phase 1 Study.
Jeter MD; Gomez D; Nguyen QN; Komaki R; Zhang X; Zhu X; O'Reilly M; Fossella FV; Xu T; Wei X; Wang H; Yang W; Tsao A; Mohan R; Liao Z
Int J Radiat Oncol Biol Phys; 2018 Mar; 100(3):730-737. PubMed ID: 29248169
[TBL] [Abstract][Full Text] [Related]
20. Dosimetric comparison between proton beam therapy and photon radiation therapy for locally advanced non-small cell lung cancer.
Wu CT; Motegi A; Motegi K; Hotta K; Kohno R; Tachibana H; Kumagai M; Nakamura N; Hojo H; Niho S; Goto K; Akimoto T
Jpn J Clin Oncol; 2016 Nov; 46(11):1008-1014. PubMed ID: 27511988
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
